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Abstract: 
It has recently been demonstrated that purified NAD(P)H:quinone oxidoreductase 1 (NQO1) is 
able to scavenge superoxide (O 2 •− ) though the rate of reaction of O 2 •− with NQO1 is much 
lower than the rate of enzymatic dismutation catalyzed by superoxide dismutase (SOD). This 
study was undertaken to determine if the endogenously expressed NQO1 in cardiovascular cells 
could scavenge O 2 •− . We observed thatNQO1 was highly expressed in cardiovascular cells, 
including rat aortic smooth muscle A10 and cardiac H9c2 cells, as well as normal human aortic 
smooth muscle and endothelial cells. NQO1, but not SOD in the cardiovascular cells was highly 
inducible by 3H-1,2-dithiole-3-thione (D3T). Cytosols from H9c2 and human aortic smooth 
muscle cells (HASMCs) were isolated to determine the O 2 •− scavenging ability of the 
endogenously expressed NQO1 by using pyrogallol autooxidation assay. We showed that 
cytosols from the above cells inhibited pyrogallol autooxidation in an NADPH or NADH-
dependent manner. The NADH/NADPH-dependent inhibition of pyrogallol autooxidation by the 
cytosols was completely abolished by the NQO1-specific inhibitor, ES936, suggesting that the 
endogenously expressed NQO1 could scavenge O 2 •− . In the presence of NADH/NADPH, 
cytosols from D3T-treated cells showed increased ability to scavenge O 2 •− as compared to 
cytosols from untreated cells. This increased ability to scavenge O 2 •− was also completely 
reversed by ES936. 5-(Diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide spin-trapping 
experiments using potassium superoxide as a O 2 •− generator further confirmed the ability 
of NQO1 from HASMCs to scavenge O 2 •− . The spin-trapping experiments also showed that 
induction of NQO1 by D3T in HASMCs augmented the O 2 •− scavenging ability. Taken 
together, these results demonstrate that the highly expressed and inducible endogenous NQO1 in 
cardiovascular cells may act as a potential O 2 •− scavenger. 
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Introduction 
NAD(P)H:quinone oxidoreductase 1 (NQO1), also referred to as DT-diaphorase, is a 
flavoprotein that catalyzes the two-electron reduction of quinones and quinoid compounds to 
hydroquinones, using either NADH or NADPH as the electron donor [1]. The two-electron 
reduction of redox-active quinones by NQO1 to hydroquinones also bypasses the formation of 
semiquinone radicals via one-electron reduction, and thus limiting the formation of reactive 
oxygen species (ROS) [1]. NQO1 may also play an antioxidative role via reduction of cellular 
quinone compounds, such as vitamin E quinone and ubiquinone to the hydroquinone forms that 
possess excellent antioxidative properties [2, 3]. The notion that NQO1 may act as an 
antioxidative protein is further strengthened by the observations that cellular NQO1 is highly 
inducible by authentic ROS or under conditions that are known to form ROS, such as radiation 
and redox cycling compounds [4–6]. In addition to the above antioxidative properties, NQO1 has 
been shown to play an important part in regulating the stability of p53 protein via direct protein–
protein interaction [7, 8]. p53 protein is a redox-responsive transcription factor that upregulates a 
number of proteins involved in protection against oxidative stress, including glutathione 
peroxidase as well as proteins with homology to quinone oxidoreductase/NQO1 [9–11]. 
The above findings suggest that NQO1 may play a broader role in protecting cells against 
oxidative insults. In this context, Siegel et al. have recently reported that purified human 
recombinant NQO1 is able to scavenge superoxide (O 2 •− ) using NADH or NADPH as the 
electron donor [12]. It has further been demonstrated that cytosols derived from NQO1-
transfected cells are able to scavenge O 2 •− in an NQO1-dependent manner [12]. However, the 
rate of reaction of O 2 •− with NQO1 is in the order of 4 orders of magnitude less than the rate of 
enzymatic dismutation catalyzed by superoxide dismutase (SOD) [12]. This observation implies 
that in the presence of SOD, the significance of endogenous NQO1 in scavenging O 2 •−would be 
determined by its levels/activities in the cells. Although NQO1 is a ubiquitously expressed 
protein found in various mammalian tissues and cells, its levels of expression vary among 
different tissues/cells [1,13, 14]. In this regard, we previously observed that NOQ1 was highly 
expressed in cardiovascular tissues, including mouse myocardium [15] and human aortic tissue 
[14], as well as in the rat cardiac line, H9c2 cells [16]. In the present study, we further observed 
that NQO1 was highly expressed constitutively in rat aortic smooth muscle A10 cells, as well as 
in normal human aortic smooth muscle and endothelial cells, where expression of SOD was 
relatively low as compared to most other types of cells. The endogenous NQO1, but not SOD in 
the above cardiovascular cells was also highly inducible by 3H-1,2-dithiole-3-thione (D3T). 
Moreover, we demonstrated that the highly expressed and inducible endogenous NQO1 from 
cardiovascular cells was able to scavenge O 2 •− , and might act as an important endogenous 
defense against O 2 •− . 
Materials and Methods 
Chemicals and Materials 
D3T with a purity of 99.8% was generously provided by Dr. Mary Tanga at SRI International 
(Menlo Park, CA) and Dr. Linda Brady at National Institute of Mental Health (Bethesda, MD). 
RPMI 1640 medium, Dulbecco’s modified Eagle’s medium (DMEM), Ham’s F12 medium, 
penicillin, streptomycin, fetal bovine serum (FBS), horse serum, and Dulbecco’s phosphate-
buffered saline (PBS) were from Gibco-Invitrogen (Carlsbad, CA). 5-Methoxy-1,2-dimethyl-3-
[(4-nitrophenoxy)methyl]indole-4,7-dione (ES936), a potent and specific inhibitor of NQO1 was 
synthesized as described previously [17]. Anti-NQO1 and β-actin antibodies were from Santa 
Cruz Biotech (Santa Cruz, CA). 5-(Diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide 
(DEPMPO) was from Calbiochem (San Diego, CA). Endothelial cell growth supplement 
(ECGS) was from Upstate (Charlottesville, VA). All other chemicals and agents were from 
Sigma Chemical (St. Louis, MO). 
Cell Culture and Cytosol Preparation 
Rat aortic smooth muscle A10 and cardiac H9c2 cells (ATCC, Manasas, VA) were cultured in 
DMEM supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin, as 
described before [16, 18]. Normal human aortic smooth muscle cells (ATCC) were cultured in 
Ham’s F12 medium supplemented with 10% FBS, 0.01 mg/ml insulin, 0.01 mg/ml transferin, 
10 ng/ml sodium selenite, 0.03 mg/ml ECGS, 100 U/ml penicillin, and 100 μg/ml streptomycin, 
as described before [19]. Normal human aortic endothelial cells (ATCC) were cultured in Ham’s 
F12 medium supplemented with 10% FBS, 0.1 mg/ml heparin, 0.03 mg/ml ECGS, 100 U/ml 
penicillin, and 100 μg/ml streptomycin. Primary bone marrow stromal cells were isolated from 
ICR/Sv129 mice and cultured in RPMI 1640 medium supplemented with 7.5% FBS, 7.5% horse 
serum, 50 μM 2-mercaptoethanol, 0.1 mg/ml pyruvate, 100 U/ml penicillin, and 100 μg/ml 
streptomycin, as described before [20]. Peritoneal macrophages were isolated from ICR/Sv129 
mice following intraperitoneal injection of 4% thioglycollate medium, and cultured in RPMI 
1640 medium supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. 
Rat insulin-secreting RINm5F cells (ATCC) were cultured in RPMI 1640 medium supplemented 
with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin, as described before [21]. 
Human neuronal SH-Sy5y and intestinal Caco-2 cells (ATCC) were cultured in DMEM 
supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. For cytosol 
preparation, cells were harvested and washed with PBS. The cell pellets were resuspended in 
10 mM Tris–HCl buffer, pH 7.4, containing 250 mM sucrose, sonicated on ice for 5 s, and 
followed by centrifugation at 30,000 g for 15 min to remove insoluble matter, as described 
before [12]. The resulting supernatants were collected and the protein concentrations were 
measured with a Bio-Rad protein assay kit (Hercules, CA) using bovine serum albumin as the 
standard. 
Measurement of Cellular NQO1 Activity 
Cellular NQO1 activity was determined using dichloroindophenol (DCIP) as the two-electron 
acceptor, as described before [16]. In brief, the reaction mix contained in 50 mM Tris–HCl, pH 
7.5, 0.08% Triton X-100, 0.25 mM NADPH, 80 μM 2,6-dichloroindophenol (DCIP) in the 
presence or absence of 60 μM dicumarol. To an assay cuvette, 0.695 ml of reaction mix was 
added. The reaction was started by adding 5 μl of sample, and the two-electron reduction of 
DCIP was monitored at 600 nm, 25°C for 3 min. The dicumarol-inhibitableNQO1 activity was 
calculated using the extinction coefficient of 21.0 mM−1 cm−1, and expressed as nmol of DCIP 
reduced per min per mg of cellular protein. 
Measurement of Cellular SOD Activity 
SOD activity was determined by the method of Spitz and Oberley [22] with slight modifications. 
In brief, the reaction mix contained in 50 mM potassium phosphate buffer, pH 7.8, 1.33 mM 
diethylenetriaminepentaacetic acid (DTPA), 1.0 U/ml catalase, 70 μM nitroblue tetrazolium, 
0.2 mM xanthine, 50 μM bathocuproinedisulfonic acid, and 0.13 mg/ml bovine serum albumin. 
About 0.8 ml of the reaction mix was added to each cuvette, followed by addition of 100 μl of 
sample. The cuvettes were pre-warmed at 37°C for 3 min. The reaction was then initiated by 
adding 100 μl of xanthine oxidase (0.1–0.2 U/ml). The formation of formazan blue was 
monitored at 560 nm, 37°C for 5 min. Sample SOD activity was calculated using a concurrently 
run SOD (Sigma) standard curve, and expressed as units per mg of cellular protein. 
Immunoblot Analysis 
Prior to electrophoresis, the samples were diluted with 4x sample loading buffer (62.5 mM Tris–
HCl, pH 6.8, 10% glycerol, 2% SDS, 5% 2-mercaptoethanol, and 0.05% bromophenol blue) and 
heated at 95°C for 5 min. Equal amounts of protein from each sample were resolved by SDS-
PAGE on 10% gels, transferred electrophoretically to a nitrocellulose membrane (Amersham, 
Piscataway, NJ). The membrane was blocked with 5% non-fat dried milk in TTBS buffer 
containing 20 mM Tris–HCl, pH 7.4, 150 mM NaCl, and 0.05% Tween-20 at room temperature 
for 1.5 h. The membrane was incubated with primary antibodies overnight at 4°C, followed by 
washing in TTBS buffer. The membrane was then incubated with horseradish peroxidase-labeled 
secondary antibodies (Santa Cruz Biotech) for 1.5 h, followed by washing in TTBS buffer. The 
membrane was visualized using an enhanced chemiluminescence system (Amersham) and blots 
were quantified by Gel-Pro Analyzer version 4.5 (MediaCybernetics, Silver Spring, MD). 
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Analysis 
Total RNA from cells was extracted using Trizol reagent (Invitrogen) following the 
manufacturer’s instruction.cDNA synthesis and subsequent PCR reaction were performed using 
Superscript II One-Step system (Invitrogen) in a volume of 25 μl according to manufacturer’s 
instruction. The cycling conditions for RT-PCR were the following: 50°C for 30 min (reverse 
transcription), 94°C for 2 min (pre-denaturation), followed by 25 cycles of PCR amplification 
process including denaturing at 94°C for 15 s, annealing at 57°C for 30 s, and extension at 72°C 
for 45 s, and by 1 cycle of final extension at 72°C for 10 min. PCR primers were synthesized by 
the DNA/RNA Synthesis Core Facility of The Johns Hopkins University (Baltimore, MD). PCR 
products were separated by 1% agarose gel electrophoresis. Gels were stained with 0.5 μg/ml 
solution of ethidium bromide for 30 min followed by another 30 min destaining in water. The 
gels were then analyzed under ultraviolet light using an Alpha Innotech Imaging system (San 
Leandro, CA). Various amounts of total RNA were used to demonstrate a linear amplification of 
the specific mRNA. The quantitative capacity of RT-PCR in detecting mRNA levels has 
previously been characterized by our laboratory and others [21, 23]. 
Pyrogallol Autooxidation Assay 
Inhibition of pyrogallol autooxidation was performed according to the procedures described 
before [12]. Briefly, the reaction mix contained in 50 mM Tris–HCl, pH 8.0, 2 mM EDTA, 
0.2 mM NADH or NADPH, cytosol (25 μg protein) in the presence or absence of 2.5 μM ES936. 
The reaction was started by adding pyrogallol (prepared freshly in ice-cold de-ionized water) to 
give a final concentration of 0.2 mM. The autooxidation of pyrogallol was monitored at 420 nm, 
27°C for 5 min. 
Electron Paramagnetic Resonance (EPR) Spin-Trapping Assay 
For DEPMPO spin-trapping measurement of O 2 •− , EPR spectra were recorded at room 
temperature with a spectrometer (Bruker D-200 ER, IBM-Bruker), operating at X-band with a 
TM cavity, as described previously [24]. The EPR parameters were set at 100 KHz, X band 
microwave frequency, 9.5 GHz; microwave power, 20 mW (milliwatts); modulation amplitude, 
1 G (gauss); time constant, 160 s; scan time, 50 s; and receiver gain, 5 × 105. The reaction mix 
contained in PBS, pH 7.4, 0.1 mM DTPA, 0.2 mM NADH, cytosol (25 μg protein), and 10 mM 
DEPMPO in the presence or absence of 2.5 μM ES936. The reaction was started by addition of 
potassium superoxide (KO2) (prepared freshly in anhydrous dimethyl sulfoxide), and the reaction 
mixture was then immediately transferred to a capillary tube for EPR measurement at room 
temperature. Spectral simulations were performed on the EPR data by matching directly to the 
spectra as described previously [24]. 
Statistical Analyses 
All data are expressed as means ± SEM from at least three separate experiments. Differences 
between mean values of multiple groups were analyzed by one-way analysis of variance 
(ANOVA) followed by Student–Newman–Keuls test. Differences between two groups were 
analyzed by Student t-test. Statistical significance was considered at P < 0.05. 
Results 
Constitutive Expression of NQO1 in Various Types of Cells 
NQO1 is a ubiquitously distributed cellular protein in mammals [1]. Both the basal expression 
and/or the chemical inducibility of NQO1 in various cells have been investigated by our 
laboratories over the last several years. Figure 1 shows the constitutive levels of NQO1 in nine 
different types of cells used in our laboratories. Notably, the basal levels of NQO1 in rat aortic 
smooth muscle A10 and cardiac H9c2 cells, as well as in normal human aortic smooth muscle 
and endothelial cells were much higher than those in other types of cells, including mouse bone 
marrow stromal cells, mouse peritoneal macrophages, rat insulin-secreting RINm5F, human SH-
Sy5y cells, and human Caco-2 cells. Based on the assay of dicumarol-inhibitable DCIP 
reduction, levels of NQO1 in the five types of non-cardiovascular cells ranged from barely 
detectable to ∼50 nmol DCIP/min/mg protein, whereas its levels in the four types of 
cardiovascular cells ranged from ∼500 to ∼1000 nmol DCIP/min/mg protein (Fig. 1). Such high 
constitutive levels of cellular NQO1 have not been reported for other types of cells in literature. 
 
Fig. 1 Constitutive levels of NQO1 in various types of cells. Cells were cultured and 
cellular NQO1 activity was measured as described in the Materials and Methods section. Values 
represent mean ± SEM (n = 3–6) 
Induction of Endogenous NQO1 by D3T in Cardiovascular Cells 
NQO1 is known for its inducibility under various conditions, including exposure to quinone 
compounds, oxidative stress, and chemoprotectants [4–6]. As shown in Fig. 2, the highly 
expressed endogenous NQO1in the four types of cardiovascular cells examined was also highly 
inducible by D3T. Induction of NQO1 by D3T exhibited a concentration- and time-dependent 
manner. Incubation of rat cardiac H9c2 or human aortic smooth muscle cells (HASMCs) with 
various concentrations of D3T for 48 h also led to significant induction of NQO1 protein 
expression, as detected by immunoblot analysis (Fig. 3). In line with the increases of NQO1 
activity shown in Fig. 2, induction of NQO1 protein expression by D3T in H9c2 cells and 
HASMCs also showed a concentration-dependent manner. The similar extent of induction 
of NQO1 activity (Fig. 2) and protein expression (Fig. 3) by D3T in H9c2 and HASMCs 
suggested that induction of NQO1 activity by D3T shown in Fig. 2 was due to its increased 
protein expression. Figure 4 shows time-dependent increases in the levels 
of NQO1 mRNA following incubation of H9c2 and HASMCs with D3T. As shown, a significant 
increase in the levels of NQO1 mRNA was observed 1 h after D3T treatment in both types of 
cells. In H9c2 cells, mRNA levels peaked at 12 and 24 h after D3T treatment, and declined at 
48 h though the mRNA level at 48 h was still significantly higher than that at 0 h of D3T 
treatment (Fig. 4A). Notably, mRNA levels for NQO1 in HASMCs continued to increase from 1 
to 48 h following D3T treatment (Fig. 4B), suggesting sustained induction of NQO1 gene 
expression by D3T in HASMCs. Recently, Nrf2 signaling has been shown to be critically 
involved in the transcriptional activation of NQO1 gene by D3T in various types of cells, 
including mouse cardiac fibroblasts and bone marrow stromal cells [20, 25]. It is likely 
that Nrf2 signaling may also be involved in the upregulation of NQO1 by D3T in rat cardiac 
H9c2 cells as well as HASMCs. 
 
Fig. 2 Induction of NQO1 by D3T in cardiovascular cells. (Panel A), rat aortic smooth muscle 
A10 cells; (panel B), rat cardiac H9c2 cells; (panel C), human aortic endothelial cells; (panel D), 
human aortic smooth muscle cells. Cells were incubated with the indicated concentrations of 
D3T for 24 and 48 h, followed by measurement of cellular NQO1, as described in the Materials 
and Methods section. Values represent mean ± SEM (n = 3–6). *, significantly different from 
control 
 
Fig. 3 Induction of NQO1 protein expression by D3T in rat cardiac H9c2 cells (panel A) and 
human aortic smooth muscle cells (panel B). Cells were incubated with the indicated 
concentrations of D3T for 48 h, followed by immunoblot detection of cellular NQO1 protein 
expression, as described in the Materials and Methods section. Values represent mean ± SEM 
(n = 3–4). *, significantly different from control. β-Action serves as a sample loading control 
 
Fig. 4 Induction of NQO1 mRNA expression by D3T in rat cardiac H9c2 cells (panel A) and 
human aortic smooth muscle cells (panel B). Cells were incubated with 100 μM D3T for the 
indicated time points, followed by RT-PCR detection of the levels of NQO1 mRNA, as 
described in the Materials and Methods section. Values represent mean ± SEM (n = 3). *, 
significantly different from 0 h. β-Action serves as a sample loading control 
In contrast to the high basal expression as well as D3T-inducibility of NOQ1, the constitutive 
levels of SOD were relatively low in H9c2 and HASMCs (Table 1). In addition, SOD in neither 
type of the cells was inducible by D3T under the present experimental conditions (Table 1).  
Table 1 Basal levels of SOD and NQO1, and their differential inducibility by D3T in rat cardiac 
H9c2 and human aortic smooth muscle cells (HASMCs). Cells were incubated with 100 μM 
D3T for 48 h, followed by measurement of the activity of SOD and NQO1, as described in the 
Materials and Methods section 
Cell type SOD (units/mg protein) NQO1(nmol/min/mg protein) 
H9c2 cells 10.4 ± 1.4 1030 ± 150 
HASMCs 4.5 ± 0.5 978 ± 38 
H9c2 cells + D3T 9.6 ± 1.4 5007 ± 211 
HASMCs + D3T 4.3 ± 0.4 2112 ± 214 
Values represent mean ± SEM (n = 3–4) 
Inhibition of Pyrogallol Autooxidation by Endogenous NQO1 from Cardiovascular Cells 
Since rat cardiac H9c2 cells and HASMCs showed the highest levels of NQO1, we selected these 
two types of cells to further determine if the endogenously expressed NQO1 could scavenge 
O 2 •− . To this end, pyrogallol autooxidation assay was used to determine the O 2 •− scavenging 
capacity of NQO1 from H9c2 cells and HASMCs. As shown in Fig. 5, in the absence 
of NADH or NADPH, cytosol from control H9c2 cells inhibited pyrogallol autooxidation 
apparently due to the presence of SOD in the cytosol. Addition of NADH or NADPH led to 
further inhibition of pyrogallol autooxidation by the cytosol. This increased inhibition of 
pyrogallol autooxidation was completely abolished by the NQO1 specific inhibitor, ES936 [26]. 
In the absence of NADH or NADPH, cytosol from D3T-treated H9c2 cells inhibited pyrogallol 
autooxidation to the same extent as that observed with cytosol from control H9c2 cells (Fig. 5). 
Notably, in the presence of NADH or NADPH cytosol from D3T-treated H9c2 cells showed 
increased ability of inhibiting pyrogallol autooxidation as compared to cytosol from control 
H9c2 cells. Similarly, this increased inhibition of pyrogallol autooxidation was completely 
reversed by ES936 (Fig. 5). As shown, NADH or NADPH alone did not significantly affect the 
autooxidation of pyrogallol. It was also observed that the presence of ES936 (2.5 μM) alone did 
not affect the autooxidation of pyrogallol (data not shown). It is worthy of mentioning that 
ES936 at concentrations inhibiting more than 95% of cellular NQO1 activity does not affect cell 
viability, alter cellular levels of acid-soluble thiols, or inhibit other cellular reductases [26]. 
 
Fig. 5 Inhibition of pyrogallol autooxidation by cytosols from H9c2 cells. Pyrogallol 
autooxidation was determined after addition of cytosols, and NADPH (panel A), 
or NADH (panel B) in the presence or absence of ES936, as described in the Materials and 
Methods section. “Con cytosol” refers to the cytosol isolated from control H9c2 cells; “D3T 
cytosol” refers to the cytosol isolated from H9c2 cells after treatment with 100 μM D3T for 48 h. 
Values represent mean ± SEM (n = 3–5). In both panels A and B, *, significantly different from 
“Con cytosol”; In panel A, #, significantly different from “Con cytosol + NADPH”; In panel B, 
#, significantly different from “Con cytosol + NADH” 
Consistent with what observed with H9c2 cytosol, cytosol from HASMCs inhibited 
autooxidation of pyrogallol in an NADH-dependent manner. This NADH-dependent inhibition 
of pyrogallol autooxidation by cytosol from HASMCs was also completely abolished by ES936. 
Similarly, cytosol from D3T-treated HASMCs exhibited increased ability of NADH-dependent 
inhibition of pyrogallol autooxidation, as compared to cotosol from control HASMCs (Fig. 6). In 
contrast to what we observed using cytosols from HASMCs as well as H9c2 cells, cytosols from 
cells expressing low levels of NQO1 (∼40–50 nmol DCIP/min/mg protein), including mouse 
bone marrow stromal cells and rat RINm5F cells (Fig. 1), did not exert any significant 
NAD(P)H-dependent inhibition of pyrogallol autooxidation (data not shown). The levels of SOD 
in these cells were similar to those in HASMCs [20, unpublished observations]. 
 
Fig. 6 Inhibition of pyrogallol autooxidation by cytosols from human aortic smooth muscle cells 
(HASMCs). Pyrogallol autooxidation was determined after addition of cytosols and NADH in 
the presence or absence of ES936, as described in the Materials and Methods section. “Con 
cytosol” refers to the cytosol isolated from control HASMCs; “D3T cytosol” refers to the cytosol 
isolated from HASMCs after treatment with 100 μM D3T for 48 h. Values represent 
mean ± SEM (n = 3–5). *, significantly different from “Con cytosol”; #, significantly different 
from “Con cytosol + NADH” 
DEPMPO Spin-Trapping Detection of O 2 •− Scavenging Ability of Endogenous NQO1 from 
HASMCs 
DEPMPO-spin trapping technique was used to further determine the O 2 .− scavenging ability of 
the endogenous NQO1 from HASMCs. As shown in Fig. 7A, reaction of DEPMPO with 
KO2 resulted in the formation of a single DEPMPO-superoxide (DEPMPO-OOH) spin-adduct, 
indicating the generation of O 2 .−in the system. In the absence of NADH, addition of cytosol 
from control HASMCs caused a significant decrease in the levels of O 2 .− generated from KO2. 
The combination of NADH and cytosol caused a further decrease in the levels of O 2 .− , which 
was completely reversed by ES936. In the absence of NADH, cytosol from D3T-treated 
HASMCs caused a decrease in the level of O 2 .− , similar to that seen with cytosol from control 
HASMCs (Fig. 7). Notably, combination of NADH and cytosol from D3T-treated HASMCs led 
to much larger decrease in the levels of O 2 •− , as compared to the combination of NADH and 
cytosol from control HASMCs (Fig. 7). The NADH-dependent O 2 •− scavenging capacity of 
cytosol from D3T-treated HASMCs was completely reversed by ES936 (Fig. 7). 
Neither NADH nor ES936 significantly affected the formation of DEPMPO-OOH adduct 
(Fig. 7; data not shown). 
 
Fig. 7 Inhibition of DEPMPO-OOH adduct formation by cytosols from human aortic smooth 
muscle cells (HASMCs). Formation of DEPMPO-OOH adduct was detected by EPR after 
incubation of DEPMPO/KO2with cytosols and NADH in the presence or absence of ES936, as 
described in the Materials and Methods section. “Control cytosol” refers to the cytosol isolated 
from control HASMCs; “D3T cytosol” refers to the cytosol isolated from HASMCs after 
treatment with 100 μM D3T for 48 h. Panel (A) shows representative EPR spectra; Values in 
panel (B) represent mean ± SEM (n = 4–7). *, significantly different from “KO2 + Control 
cytosol”; #, significantly different from “KO2 + Control cytosol + NADH” 
Discussion 
The much lower reaction rate constant between NQO1 and O 2 •− as compared to that between 
SOD and O 2•− [12] implies that in order for NQO1 to scavenge O 2 •− in a cellular environment 
with SOD, it needs to be present at high levels. Indeed, as described in the Results section, 
cytosols from cells expressing low levels of NQO1 (∼40–50 nmol DCIP/min/mg protein) did not 
exhibit any significant NQO1-dependent ability of scavenging O 2 •− . The present study 
demonstrated that cardiovascular cells, including rat aortic smooth muscle A10, cardiac H9c2 
cells, as well as normal human aortic smooth muscle and endothelial cells expressed 
constitutively high levels of NQO1 (∼500–1000 nmol DCPI/min/mg protein). The high basal 
levels of NQO1 in normal human aortic smooth muscle and endothelial cells observed in the 
present study are in line with a previous report by Siegel et al. showing that human aortic tissue 
expresses high levels of NQO1 protein [14]. While the significance for the presence of high 
levels of NQO1 in cardiovascular tissue/cells remains to be fully understood, one possibility 
could be that the highly expressed endogenous NQO1 in cardiovascular tissue/cells could act as a 
potential defense mechanism for O 2 •− . In this context, levels of SOD is relatively low in 
cardiovascular tissue/cells [6, 27, Table 1]. The results of the present study further demonstrated 
that the endogenously expressed NQO1 from cardiovascular cells could scavenge O 2 •−generated 
from two different sources, i.e., pyrogallol autooxidation and KO2. 
In an alkaline environment, pyrogallol autooxidizes and generates O 2 •− , which in turn 
propagates the autooxidation process [28, 29]. Scavengers of O 2 •− are able to inhibit the 
autooxidation of pyrogallol, and as such pyrogallol autooxidation assay is widely used to detect 
SOD activity or the capacity of other O 2 •−scavenging compounds [28, 29]. In the absence of 
exogenously added NADH or NADPH, inhibition of pyrogallol autooxidation by cytosols as 
shown in Figs. 5 and 6 was apparently due to the presence of SOD in the cytosols. Since SOD 
was not induced by D3T, cytosols from control cells versus D3T-treated cells showed the same 
capacity of inhibiting pyrogallol autooxidation in the absence of NADH or NADPH (Figs. 5 
and 6). The NADH- or NADPH-dependent inhibition of pyrogallol autooxidation by cytosols 
was completely reversed by the NQO1 specific inhibitor, ES936, suggesting that the 
endogenously expressed NQO1 could scavenge O 2 •− . This notion was further strengthened by 
the observation that in the presence of NADH or NADPH cytosol from D3T-treated cells showed 
increased capacity of inhibiting pyrogallol autooxidation as compared to cytosol from control 
cells (Figs. 5 and 6). As shown in Table 1, D3T treatment led to induction of NQO1 but not SOD 
in H9c2 and HASMCs. Notably, the increased inhibition of pyrogallol autooxidation by cytosol 
from D3T-treated cells was not proportionally related to the induction of cellular NQO1 by D3T 
(Figs. 5 and 6, Table 1). For example, D3T treatment led to a ∼5-fold induction of NQO1 in 
H9c2 cells, but the NADH/NADPH-dependent %inhibition of pyrogallol autooxidation by the 
cytosol was only augmented by ∼2–2.5-fold. Similarly, the 2-fold induction of NQO1 by D3T in 
HASMCs led to a less than 2-fold increase in the %inhibition of pyrogallol autooxidation 
(Fig. 6). While the exact reason for the above discrepancy remains unknown, one possibility was 
that D3T might induce some cellular enzymes, which could potentially interfere with pyrogallol 
autooxidation. 
To further demonstrate the ability of endogenous NQO1 from cardiovascular cells to scavenge 
O 2 •− , KO2was used as another source of O 2 •− , and the levels of O 2 •− were detected by 
DEPMPO spin-trapping. EPR spin-trapping in conjunction with KO2 provides more definitive 
evidence for the ability of O 2 •−scavengers. Using this technique, Siegel et al. [12] have 
demonstrated that purified NQO1 scavenges O 2 •−in an NADH-dependent manner. They have 
further shown that the ability of purified NQO1 plus NADH to scavenge O 2 •− is completely 
diminished in the presence of ES936 [12]. As shown in Fig. 7, in the absence of NADH, cytosol 
from HASMCs decreased the formation of DEPMPO-OOH adduct, indicating the ability of 
scavenging O 2 •− . This observation is in line with the results obtained with the pyrogallol 
autooxidation assay (Figs. 5 and 6). Addition of NADH to cytosol from control HASMCs further 
decreased the formation of DEPMPO-OOH adduct, and this NADH-dependent effect was 
completely reversed by ES936, suggesting that the endogenous NQO1 from HASMCs was able 
to significantly scavenge O 2 •− . Notably, the decrease in the formation of DEPMPO-OOH 
adduct by NQO1 was similar to that caused by SOD (i.e., cytosol in the absence of NADH). This 
observation suggested that in HASMCs NQO1 and SOD might play an equally important part in 
scavenging O 2 •− . Although the reaction rate constant between NQO1 and O 2 •− is much lower 
than that between SOD and O 2 •− , the extremely high levels of NQO1 plus the relative 
deficiency of SOD in HASMCs (Table 1) would make it possible for NQO1 to play an important 
part in scavenging O 2 •− . As shown, cytosol from D3T-treated HASMCs decreased the 
formation of DEPMPO-OOH adduct to the same extent as that seen with control HASMC-
derived cytosol (Fig. 7). This observation is consistent with the results in Table 1, showing that 
D3T treatment did not affect the levels of SOD in HASMCs. In contrast, in the presence 
of NADH cytosol from D3T-treated HASMCs caused a further remarkable decrease in the 
formation of DEPMPO-OOH adduct, and this effect was completely reversed by ES936 (Fig. 7). 
This result suggested that induction of NQO1 by D3T in HASMCs could lead to an enhanced 
ability of scavenging O 2 •−. Notably, the enhanced O 2 •− scavenging ability by NQO1 (Fig. 7) 
was proportionally related to the extent of induction of this enzyme by D3T in HASMCs 
(Table 1), further supporting the notion that the highly expressed and inducible NQO1 in 
HASMCs could act as an important O 2 •− scavenger. 
In summary, the results of the present study demonstrate that NQO1 is highly expressed and 
inducible in cardiovascular cells where SOD expression is relatively low, and that the 
endogenously expressed NQO1from cardiovascular cells appears to act as an important 
scavenger for O 2 •− . These results are also in line with the early study by Siegel et al., showing 
that purified recombinant human NQO1 as well as cytosols from NQO1-transfected cells posses 
NAD(P)H-dependent O 2 •− scavenging activity [12]. These results also suggest that the 
endogenously expressed NQO1 in cardiovascular cells, including normal human vascular smooth 
muscle and endothelial cells may be an important defense mechanism for O 2 •− . The 
significance for cardiovascular cellular NQO1 to act as a potentially important defense 
mechanism for O 2 •− is further strengthened by the observation that induction of NQO1 by D3T 
augments its ability of scavenging O 2 •−(Fig. 7). In this context, as stated above, NQO1 is known 
for its high inducibility by chemoprotectants as well as under various stress conditions [4–6]. 
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